Company Adiuvo Investments S.A.

Equities

ADV

PLADVIV00015

Investment Management & Fund Operators

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Sector Venture Capital

Market Closed - Warsaw S.E. Other stock markets 11:55:41 2024-04-26 am EDT			5-day change	1st Jan Change
0.912 ^PLN	-2.98%		-2.98%	+2.47%

2023	Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.

Number of employees: 8

PLN in Million	2021	Weight	2022	Weight	Delta
Other 184.6 %	2	97.9 %	1	184.6 %	-47.20%
Consolidation Adjustments -145.9 %	-1	-70.7 %	-1	-145.9 %	-42.24%
Nutraceutical Platform 61.2 %	1	72.4 %	0	61.2 %	-76.33%

PLN in Million	2021	Weight	2022	Weight	Delta
Poland 100.0 %	2	100.0 %	0	100.0 %	-72.01%

Managers	Title	Age	Since
Marek Jan Orlowski CEO	Chief Executive Officer	55	12-12-31
William George COO	Chief Operating Officer	-	-
Ernest Bucior CTO	Chief Tech/Sci/R&D Officer	-	12-12-31
Marzena Kunicka ADM	Chief Administrative Officer	-	-
Michael Grzebyk CTO	Chief Tech/Sci/R&D Officer	-	-
Przemyslaw Cipyk BRD	Director/Board Member	-	-
Anna Elzbieta Aranowska-Bablok IRC	Investor Relations Contact	44	-
Karolina Nózka SAM	Sales & Marketing	-	-

Members of the board	Title	Age	Since
Krzysztof Adam Laskowski BRD	Director/Board Member	44	16-11-29
Pawel Nauman BRD	Director/Board Member	54	-
Przemyslaw Cipyk BRD	Director/Board Member	-	-
Jerzy Jan Lopatynski BRD	Director/Board Member	-	-
Boguslaw Ulijasz CHM	Chairman	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	13,174,346	5,516,087 ( 41.87 %)	0	41.87 %

Name	Equities	%	Valuation
TFI PZU SA 1.899 %	250,170	1.899 %	60 101 zł
Nordea PTE SA 0.4583 %	60,384	0.4583 %	14 507 zł
Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych SA 0.0645 %	8,500	0.0645 %	2 042 zł
Quercus TFI SA (Investment Management) 0.0303 %	3,998	0.0303 %	960 zł

Adiuvo Investment SA

ul. Gen. Józefa Zajaczka 11/14

01-510, Warsaw

+48 22 243 47 990

http://www.adiuvoinvestments.com

Name	Category and Sector
AIRWAY MEDIX S.A.	Medical Specialties
Biovo Sp zoo
Nutra Sp zoo
E-SHOPPING GROUP S.A.	Pharmaceuticals: Major

Financials

Banking & Investment Services

Investment Banking & Investment Services

Investment Management & Fund Operators

Venture Capital

	1st Jan change	Capi.
ADIUVO INVESTMENTS S.A.	+2.47%	2.97M
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+14.40%	3.06B
HBM HEALTHCARE INVESTMENTS AG	+2.96%	1.42B
CION INVESTMENT CORPORATION	+1.15%	616M
VERUSA HOLDING	+35.79%	577M
MOLTEN VENTURES PLC	-10.84%	579M
OCTOPUS APOLLO VCT PLC	-4.17%	492M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+33.85%	488M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	304M

Venture Capital